Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Unlocking the potential: SLU-PP-332 and the future of exercise Enhancement and Metabolic health
View through CrossRef
The synthetic oestrogen receptor-related orphan receptor (ERR) agonist SLU-PP-332 exhibits promising potential in revolutionizing fitness and weight loss strategies. Through its activation of ERRs, SLU-PP-332 enhances energy expenditure, increases fatty acid oxidation, and reduces fat mass buildup. Studies indicate its ability to mimic exercise-induced metabolic pathways, resulting in improved endurance and weight loss in mice. While long-term implications are yet to be fully understood, initial trials show no significant adverse effects. SLU-PP-332 targets ERRs found in various human organs, influencing vital metabolic processes. With implications for treating metabolic disorders like obesity, type 2 diabetes, and heart failure, SLU-PP-332 emerges as a novel therapeutic agent. Its biological activity, structure, and solubility data support its potential as a small molecule drug in endocrinology and metabolic diseases. Further research is warranted to elucidate its long-term effects and refine its structure for future clinical applications
Title: Unlocking the potential: SLU-PP-332 and the future of exercise Enhancement and Metabolic health
Description:
The synthetic oestrogen receptor-related orphan receptor (ERR) agonist SLU-PP-332 exhibits promising potential in revolutionizing fitness and weight loss strategies.
Through its activation of ERRs, SLU-PP-332 enhances energy expenditure, increases fatty acid oxidation, and reduces fat mass buildup.
Studies indicate its ability to mimic exercise-induced metabolic pathways, resulting in improved endurance and weight loss in mice.
While long-term implications are yet to be fully understood, initial trials show no significant adverse effects.
SLU-PP-332 targets ERRs found in various human organs, influencing vital metabolic processes.
With implications for treating metabolic disorders like obesity, type 2 diabetes, and heart failure, SLU-PP-332 emerges as a novel therapeutic agent.
Its biological activity, structure, and solubility data support its potential as a small molecule drug in endocrinology and metabolic diseases.
Further research is warranted to elucidate its long-term effects and refine its structure for future clinical applications.
Related Results
[RETRACTED] Rhino XL Male Enhancement v1
[RETRACTED] Rhino XL Male Enhancement v1
[RETRACTED]Rhino XL Reviews, NY USA: Studies show that testosterone levels in males decrease constantly with growing age. There are also many other problems that males face due ...
PO-180 Effect of Accumulated Exercise and Continuous Exercise on Energy Metabolism
PO-180 Effect of Accumulated Exercise and Continuous Exercise on Energy Metabolism
Objective Sedentary behavior is the main feature of modern lifestyle, which relate to most chronic diseases. Therefore, it has great significance in both theory and practice of w...
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
PO-231 Effects of exercise on muscle atrophy in simulated weightless rats
Objective Insufficient physical activity, aerospace weight loss, and fixed treatment of fractures, tendons, and neuropathy, or the resulting muscle atrophy caused by reduced exerci...
One Health and the Environment at SLU: Current Status and Opportunities
One Health and the Environment at SLU: Current Status and Opportunities
This report explores the development and integration of the environmental pillar of One Health at SLU. Despite SLU’s strong expertise in environmental and ecological sciences, its ...
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Abstract
Exercise is recommended in the treatment of Type 2 Diabetes and can improve insulin sensitivity [1]. However, previous evidence suggests that exercise at d...
PO-285 A review of effects of exercise on the quality of life in breast cancer survivors
PO-285 A review of effects of exercise on the quality of life in breast cancer survivors
Objective Breast cancer is one of the most common malignant tumors in women.The number of women diagnosed with breast cancer each year is also increasing.It is also the leading cau...
Exercise Self-efficacy, Perceived Benefits, and Barriers to Exercise Among Patients Following Acute Myocardial Infarction
Exercise Self-efficacy, Perceived Benefits, and Barriers to Exercise Among Patients Following Acute Myocardial Infarction
Background
Increasing patient adherence to regular exercise post acute myocardial infarction (AMI) is a major goal after hospitalization. It is therefore essential to i...
Perceived barriers and facilitators to workplace exercise participation
Perceived barriers and facilitators to workplace exercise participation
Purpose
Workplace exercise programmes have been shown to increase employee participation in physical activities and improve health and fitness in the short-term. However, the limit...